文献速递血栓与止血

F9基因重新编码的结构、功能和免疫原性影响

Structural, functional, and immunogenicity implications of F9 gene recoding.
PubMed 文献 · Blood Adv · 2022-01-01

血友病B由凝血因子IX(FIX)活性缺陷引起,密码子优化通过同义密码子替换提高重组蛋白表达,但可能改变蛋白特性。本研究评估多个F9重新编码变体,发现其构象改变、局部翻译动力学差异、与MHC II类分子结合的FIX衍生肽呈现不同,且过表达导致翻译后修饰不充分,提示重新编码的F9产品存在功能和免疫原性风险。

要点

  • F9基因重新编码可改变蛋白构象和局部翻译动力学。
  • 重新编码的FIX蛋白与MHC II类分子结合的肽段呈现不同,提示免疫原性风险不同。
  • 基因重新编码过表达导致翻译后修饰不充分。

核心结论

  • 重新编码的F9产品可能存在功能和免疫原性风险,这些发现对其他基因重新编码的重组蛋白具有普遍适用性。

研究设计与样本

  • 评估多个F9重新编码变体,以探索密码子使用偏倚对蛋白特性的影响。

主要发现

  • 详细评估显示重新编码构建体构象改变。
  • 核糖体图谱翻译动力学分析显示局部翻译动力学差异。
  • MHC相关肽蛋白质组学分析显示,与野生型相比,重新编码构建体与MHC II类分子结合的FIX衍生肽呈现不同。
  • 翻译后修饰分析表明,基因重新编码过表达导致翻译后加工不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hemophilia B is a blood clotting disorder caused by deficient activity of coagulation factor IX (FIX). Multiple recombinant FIX proteins are currently approved to treat hemophilia B, and several gene therapy products are currently being developed. Codon optimization is a frequently used technique in the pharmaceutical industry to improve recombinant protein expression by recoding a coding sequence using multiple synonymous codon substitutions. The underlying assumption of this gene recoding is that synonymous substitutions do not alter protein characteristics because the primary sequence of the protein remains unchanged. However, a critical body of evidence shows that synonymous variants can affect cotranslational folding and protein function. Gene recoding could potentially alter the structure, function, and in vivo immunogenicity of recoded therapeutic proteins. Here, we evaluated multiple recoded variants of F9 designed to further explore the effects of codon usage bias on protein properties. The detailed evaluation of these constructs showed altered conformations, and assessment of translation kinetics by ribosome profiling revealed differences in local translation kinetics. Assessment of wild-type and recoded constructs using a major histocompatibility complex (MHC)-associated peptide proteomics assay showed distinct presentation of FIX-derived peptides bound to MHC class II molecules, suggesting that despite identical amino acid sequence, recoded proteins could exhibit different immunogenicity risks. Posttranslational modification analysis indicated that overexpression from gene recoding results in suboptimal posttranslational processing. Overall, our results highlight potential functional and immunogenicity concerns associated with gene-recoded F9 products. These findings have general applicability and implications for other gene-recoded recombinant proteins.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Katneni UK, Alexaki A, Hunt RC, et al. Structural, functional, and immunogenicity implications of F9 gene recoding. Blood Adv. 2022. PMID: 35413099. doi:10.1182/bloodadvances.2022007094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。